Bayview Pharmacy's Estriol/Estradiol [50%/50%] 0.25-1 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as menopause, osteoporosis, uterine prolapse, vaginal atrophy, and dyspareunia. The slow-release feature reduces dosing frequency and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present our unique slow release capsule formulation of Estriol/Estradiol [50%/50%] 0.25-1 mg. This innovative formulation is designed to provide a sustained release of the hormones Estriol and Estradiol, both of which play a crucial role in the regulation of female hormones. The slow release capsule formulation is made possible by the use of Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
The slow release of these hormones offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Estriol and Estradiol are both vital for the regulation of female hormones. Our formulation ensures a sustained release of these hormones, which can help to alleviate the severity of menopausal symptoms, manage endometriosis, and treat uterine fibroids.
If you have any questions about this formulation or how it can benefit you, please do not hesitate to reach out to us. At Bayview Pharmacy, we are dedicated to providing you with the best possible care and treatment options.
This compounded formulation of Estriol/Estradiol [50%/50%] 0.25-1 mg Slow Release Capsules is designed to provide a controlled and prolonged release of the active ingredients. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance.
The Estriol/Estradiol [50%/50%] 0.25-1 mg Slow Release Capsules are used to treat a variety of conditions. They are commonly prescribed for the management of menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. They are also used in the treatment of osteoporosis to help increase bone density. In addition, these capsules are used to manage endometriosis, a condition where tissue that normally lines the uterus grows outside of it. They can also be used in the treatment of breast cancer to help reduce the risk of recurrence, and to manage symptoms of premenstrual syndrome (PMS).
It is important to be aware that this formulation of Estriol/Estradiol [50%/50%] 0.25-1 mg Slow Release Capsules may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. Furthermore, this formulation may increase the risk of blood clots, stroke, and heart attack. Therefore, it is crucial to discuss any other medications you are currently taking with your healthcare provider before starting this medication.
If you have any questions or concerns about this formulation of Estriol/Estradiol [50%/50%] 0.25-1 mg Slow Release Capsules, please do not hesitate to reach out. We are here to provide you with the information and support you need to make informed decisions about your health.
This formulation is a slow-release capsule that contains a balanced combination of estriol and estradiol, two hormones naturally produced by the body and crucial for numerous physiological functions. The capsule is available in strengths ranging from 0.25 to 1 mg, providing flexibility in dosage based on individual patient needs.
The primary use of this formulation is to alleviate a variety of disease states, including menopausal symptoms, osteoporosis, and vaginal atrophy. When taken as directed, it can significantly reduce menopausal symptoms such as hot flashes, night sweats, and vaginal dryness, improving the quality of life for many women.
Furthermore, this formulation can help mitigate the risk of osteoporosis by enhancing bone density and reducing the likelihood of fractures. It can also alleviate symptoms of vaginal atrophy, such as itching, burning, and dryness, providing relief and comfort.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, offering sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is crucial to take this medication as directed by your healthcare provider, ideally at the same time each day without skipping doses. To ensure optimal absorption, it is recommended to take the capsules with food or a full glass of water. Please note that it may take several weeks for the full effects of the medication to become apparent.
If you have any questions or concerns about this formulation or its mechanism of action, please do not hesitate to contact us.
This is a compounded formulation of Estriol and Estradiol, two forms of estrogen, in a 50%/50% ratio. The capsule is designed to release these hormones gradually over an extended period of time, offering sustained therapeutic effects.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time.
Slow-release capsules offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications requiring a controlled and prolonged release profile.
As these are slow-release capsules, the frequency of dosing is typically less than with regular medications. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and condition.
Estriol and Estradiol are forms of estrogen, a female hormone. They are used to treat symptoms of menopause such as hot flashes, and vaginal dryness, burning, and irritation. They can also be used in the treatment of osteoporosis.
As with any medication, there can be side effects. These can include nausea, vomiting, bloating, stomach cramps, changes in weight or appetite, and breast tenderness. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
These capsules are typically prescribed for women experiencing symptoms of menopause or osteoporosis. They should not be used by individuals who are allergic to estrogens or any components of the capsule. Always consult your healthcare provider before starting any new medication.
Estrogens should not be used during pregnancy or while breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, you should discuss this with your healthcare provider.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Store these capsules at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth